Novavax (NVAX) Acquisitions (2020)

Novavax (NVAX) recorded quarterly Acquisitions of $1.3 million in Q4 2020.

Novavax (NVAX) Acquisitions (2020) Analysis & Trends

Novavax's Acquisitions history runs 1 years deep, the most recent figure standing at $1.3 million for Q4 2020.

In Q4 2020, Acquisitions changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2021 stood at $1.3 million (changed 0.0% YoY), while the FY2020 annual figure was $165.5 million, changed N/A from the prior year.
Acquisitions was $1.3 million for Q4 2020 at Novavax.
In the past five years, Acquisitions ranged from a high of $1.3 million in Q4 2020 to a low of $1.3 million in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Novavax	1.49 Bn	931.98 Mn	108.82 Mn	-

Historic Data

Download Data

Date	Value
Dec 31, 2020	1.31 Mn